Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial)

被引:42
|
作者
Gomes, M. [2 ]
Soares, M. O. [1 ]
Dumville, J. C.
Lewis, S. C. [3 ]
Torgerson, D. J.
Bodenham, A. R. [4 ]
Gough, M. J. [5 ]
Warlow, C. P. [3 ]
机构
[1] Univ York, Ctr Hlth Econ, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England
[2] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England
[3] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland
[4] Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England
[5] Leeds Gen Infirm, Vasc Surg Unit, Leeds, W Yorkshire, England
关键词
EFFECTIVENESS ACCEPTABILITY CURVES; ASYMPTOMATIC PATIENTS; REGRESSION METHODS; RANDOMIZED-TRIAL; ENDARTERECTOMY; STENOSIS;
D O I
10.1002/bjs.7110
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Health outcomes and costs are both important when deciding whether general (GA) or local (LA) anaesthesia should be used during carotid endarterectomy. The aim of this study was to assess the cost-effectiveness of carotid endarterectomy under LA or GA in patients with symptomatic or asymptomatic carotid stenosis for whom surgery was advised. Methods: Using patient-level data from a large, multinational, randomized controlled trial (GALA Trial) time free from stroke, myocardial infarction or death, and costs incurred were evaluated. The cost-effectiveness outcome was incremental cost per day free from an event, within a time horizon of 30 days. Results: A patient undergoing carotid endarterectomy under LA incurred fewer costs (mean difference 178) pound and had a slightly longer event-free survival (difference 0.16 days, but the 95 per cent confidence limits around this estimate were wide) compared with a patient who had GA. Existing uncertainty did not have a significant impact on the decision to adopt LA, over a wide range of willingness-to-pay values. Conclusion: If cost-effectiveness was considered in the decision to adopt GA or LA for carotid endarterectomy, given the evidence provided by this study, LA is likely to be the favoured treatment for patients for whom either anaesthetic approach is clinically appropriate.
引用
收藏
页码:1218 / 1225
页数:8
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial
    Byford, Sarah
    Cary, Maria
    Barrett, Barbara
    Aldred, Catherine R.
    Charman, Tony
    Howlin, Patricia
    Hudry, Kristelle
    Leadbitter, Kathy
    Le Couteur, Ann
    McConachie, Helen
    Pickles, Andrew
    Slonims, Vicky
    Temple, Kathryn J.
    Green, Jonathan
    BMC PSYCHIATRY, 2015, 15
  • [42] Long-Term Outcome and Cost-Effectiveness of Complete Versus Assisted Video-Assisted Thoracic Surgery for Non-Small Cell Lung Cancer
    He, Jianxing
    Shao, Wenlong
    Cao, Christopher
    Yan, Tristan
    Wang, Daoyuan
    Xiong, Xin-Guo
    Yin, Weiqiang
    Xu, Xin
    Chen, Hanzhang
    Qiu, Yuan
    Zhong, Baoliang
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (02) : 162 - 168
  • [43] Cost-effectiveness analysis of a resource-intensive approach versus minimally invasive strategy for high-risk transcatheter aortic valve replacement patients
    Mayhew, Christopher R.
    Gallagher, Andrew
    Bensimhon, Ariel
    Dauerman, Harold L.
    Tsai, Mitchell H.
    Martin, Jacob A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (04) : 217 - 227
  • [44] Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers
    Chen, L. Andy
    Kim, Jaewhan
    Boucher, Kenneth
    Terakedis, Breanne
    Williams, Britney
    Nickman, Nancy A.
    Gaffney, David K.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 521 - 528
  • [45] A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexed in Second-Line Chemotherapy for Stage IIIb or IV Non-Small Cell Lung Cancer in China
    Yu, Yong-feng
    Chen, Zhi-wei
    Zhou, Zhen
    Song, Zheng-bo
    Li, Zi-ming
    Jian, Hong
    Zhang, Yi-fei
    Lu, Shun
    CHEMOTHERAPY, 2010, 56 (06) : 472 - 477
  • [46] Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer -: Results of the Federation Francophone de Cancerologie Digestive (FFCD) 9601 randomized trial
    Borget, Isabelle
    Auperin, Anne
    Pignon, Jean-Pierre
    Abbas, Moncef
    Bouche, Olivier
    Mousseau, Mireille
    Raoul, Jean-Luc
    Bedenne, Laurent
    Cassan, Philippe
    Clavero-Fabri, Marie-Christine
    Stremsdoerfer, Noel
    Nasca, Salvador
    Queuniet, Anne-Marie
    Ducreux, Michel
    ONCOLOGY, 2006, 71 (1-2) : 40 - 48
  • [47] A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions
    Vossen, Rianne J.
    Philipszoon, Pilar C.
    Vahl, Anco C.
    Van Swijndregt, Alexander D. Montauban
    Leijdekkers, Vanessa J.
    Balm, Ron
    JOURNAL OF ENDOVASCULAR THERAPY, 2019, 26 (02) : 172 - 180
  • [48] Eversion technique versus conventional endarterectomy with patch angioplasty in carotid surgery: protocol for a systematic review with meta-analyses and trial sequential analysis of randomised clinical trials
    Marsman, Martijn S.
    Wetterslev, Jorn
    Vriens, Patrick W. H. E.
    Bleys, Ronald L. A. W.
    Jahrome, Abdelkarime Kh.
    Moll, Frans L.
    Keus, Frederik
    Koning, Giel G.
    BMJ OPEN, 2020, 10 (04):
  • [49] Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)
    Rodriguez, Alfredo E.
    Palacios, Igor
    Rodriguez-Granillo, Alfredo M.
    Mieres, Juan R.
    Tarragona, Sonia
    Fernandez-Pereira, Carlos
    Solorzano, Leonardo
    Pauletto, Ricardo
    Serruys, Patrick W.
    Antoniucci, David
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (05) : 815 - 821
  • [50] Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness
    Gurusamy, Kurinchi
    Vale, Claire L.
    Pizzo, Elena
    Bhanot, R.
    Davidson, Brian R.
    Mould, Tim
    Mughal, Muntzer
    Saunders, Mark
    Aziz, Omer
    O'Dwyer, Sarah
    BMJ OPEN, 2020, 10 (05):